U.S. awards new $628 million contract to boost output of potential COVID-19 vaccine

U.S. awards new $628 million contract to boost output of potential COVID-19 vaccine

U.S. awards new $628 million contract to boost output of potential COVID-19 vaccineAs drugmakers race to develop vaccines, tests and therapies for the disease, the United States is looking to secure manufacturing capacity under its "Operation Warp Speed" program announced in May to accelerate vaccine development. "Securing more manufacturing capacity here in America for candidates that make it to the final stages of Operation Warp Speed will help get a vaccine to American patients without a day wasted," Department of Health and Human Services (HHS) Secretary Alex Azar said in a statement. The HHS task order with Emergent falls under an existing contract with the Biomedical Advanced Research and Development Authority (BARDA), a U.S. federal agency that funds disease-fighting technology.